Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

EconomyDaily Composite

Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement